The pharmaceuticals sector, which has had a woeful time of it lately, was generally stronger. Schering-Plough, which said it was paying the government a record $500m to settle allegations relating to drug manufacturing practices, recovered $1.29 or 5.2% to $26.04. Abbott Labs, which has said that a plant in Illinois failed a government inspection, retrieved $1.88 or 4% to $47.63.